Clinical trials and p-values, beware of the extremes

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 3, 2004, Pages 300-304

  Cleophas, Ton J ^a,b  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^b European Interuniversity   (France)

Author keywords

Clinical trials; Data cleaning; Extreme p values; p values; Random sampling

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; DATA ANALYSIS; HEART ARRHYTHMIA; HUMAN; HYPOTHESIS; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; RANDOMIZATION; SAMPLE SIZE; SAMPLING; SEPSIS; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS; SWAN GANZ CATHETER;

AREA UNDER CURVE; CHI-SQUARE DISTRIBUTION; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; PROBABILITY; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLE SIZE; STATISTICAL DISTRIBUTIONS;

EID: 1842737105     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.054     Document Type: Article

References (9)

1. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al., for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.
2. Sandham JD, Hull RD, Brand RF, Knox L, Pineo GF, Doig CJ, et al., for the Canadian Critical Care Clinical Trials Group. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003;348:5-14.
3. LIPID Study Group. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet 2002;359:1379-87.
4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
5. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
6. Seppälä H, Nissinen A, Järvinen H, Huovinen S, Henrikson T, Herva E, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992;326:292-7.
7. Rafal ES, Griffiths CE, Ditre CM, Finkel LJ, Hamilton TA, Ellis CN, et al. Topical retinoin treatment for liver spots associated with photodamage. N Engl J Med 1992;326: 368-74.
8. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 1992;326:431-6.
9. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948;2:769-82.